How BioNTech went from a little-known biotech company to creating the Covid vaccine

It was Jan. 24, 2020 when BioNTech CEO Uğur Şahin knew that Covid-19 was prone to develop into a world pandemic. 

Although it was over a month and a half earlier than the World Well being Group formally declared a pandemic, Sahin met along with his spouse, BioNTech’s co-founder and chief medical officer Özlem Türeci. Collectively, they agreed to redirect a lot of the firm’s sources to growing a vaccine. 

“He approached me and defined his ideas and his his fears,” Türeci stated. “And it was instantly clear to each of us that the expertise we had, and which we had already clinically developed, that might assist to make sure a speedy response.”

Up till that time, BioNTech was primarily targeted on growing novel most cancers therapies. The corporate was little-known internationally. However the founders have been assured within the potential of their mRNA expertise, which they knew might set off a strong immune response. BioNTech knew that to efficiently produce, check and manufacture a Covid vaccine on a world scale, it could want an even bigger accomplice. The corporate already had a relationship with Pfizer, having labored with them since 2018 to develop an mRNA-based flu vaccine, which is in medical trials. So, BioNTech turned to them.

The businesses succeeded. In August, the Pfizer-BioNTech vaccine became the first to gain full FDA approval.

Watch the video to be taught in regards to the rise of BioNTech.

How BioNTech went from a little-known biotech firm to creating the Covid vaccine Source link How BioNTech went from a little-known biotech firm to creating the Covid vaccine

Leave a Reply

Your email address will not be published. Required fields are marked *